Cargando…

l-Methionine may modulate the assembly of SARS-CoV-2 by interfering with the mechanism of RNA polymerase

Coronaviruses have received worldwide attention following several severe acute respiratory syndrome (SARS) epidemics. In 2019, the first case of coronavirus disease (COVID-19) caused by a novel coronavirus (SARS-coronavirus 2 [CoV-2]) was reported. SARS-CoV-2 employs RNA-dependent RNA polymerase (Rd...

Descripción completa

Detalles Bibliográficos
Autor principal:	Benavides, Maximo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841269/ https://www.ncbi.nlm.nih.gov/pubmed/35185264 http://dx.doi.org/10.1016/j.mehy.2022.110798

Ejemplares similares

A synthetic defective interfering SARS-CoV-2
por: Yao, Shun, et al.
Publicado: (2021)

Computational Identification of Small Interfering RNA Targets in SARS-CoV-2
por: Chen, Wei, et al.
Publicado: (2020)

A small interfering RNA (siRNA) database for SARS-CoV-2
por: Medeiros, Inácio Gomes, et al.
Publicado: (2021)

Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
por: Zanoni, Ivan
Publicado: (2021)

Evolution of naturally arising SARS-CoV-2 defective interfering particles
por: Girgis, Samer, et al.
Publicado: (2022)

Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells
por: Qin, Zhao-ling, et al.
Publicado: (2004)

Prediction of potential small interfering RNA molecules for silencing of the spike gene of SARS-CoV-2
por: Panda, Kingshuk, et al.
Publicado: (2021)

Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence
por: Tolksdorf, Beatrice, et al.
Publicado: (2021)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020)

Structure and function of SARS-CoV-2 polymerase
por: Hillen, Hauke S
Publicado: (2021)

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
por: Pruijssers, Andrea J., et al.
Publicado: (2020)

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase
por: Wang, Quan, et al.
Publicado: (2020)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Dynamic properties of SARS-CoV and SARS-CoV-2 RNA-dependent RNA polymerases studied by molecular dynamics simulations
por: Itoh, Satoru G., et al.
Publicado: (2021)

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein
por: Kim, Jinsoo, et al.
Publicado: (2022)

Small interfering RNA inhibits SARS‐CoV nucleocapsid gene expression in cultured cells and mouse muscles
por: Zhao, Ping, et al.
Publicado: (2005)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Subtle structural differences of nucleotide analogs may impact SARS-CoV-2 RNA-dependent RNA polymerase and exoribonuclease activity
por: Madariaga-Mazón, Abraham, et al.
Publicado: (2022)

Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
por: Chien, Minchen, et al.
Publicado: (2020)

The nucleotide addition cycle of the SARS-CoV-2 polymerase
por: Bera, Subhas Chandra, et al.
Publicado: (2021)

The nucleotide addition cycle of the SARS-CoV-2 polymerase
por: Bera, Subhas Chandra, et al.
Publicado: (2021)

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
por: Kokic, Goran, et al.
Publicado: (2021)

Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021)

Mechanism of reaction of RNA-dependent RNA polymerase from SARS-CoV-2
por: Aranda, Juan, et al.
Publicado: (2022)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
por: Zandi, Keivan, et al.
Publicado: (2021)

The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme
por: Walker, Alexander P, et al.
Publicado: (2021)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
por: Shannon, A., et al.
Publicado: (2020)

RNA polymerase inaccuracy underlies SARS-CoV-2 variants and vaccine heterogeneity
por: Bradley, Catherine C., et al.
Publicado: (2022)

Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate
por: Bobiļeva, Olga, et al.
Publicado: (2021)

Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
por: Peng, Qi, et al.
Publicado: (2021)

The structure of a dimeric form of SARS-CoV-2 polymerase
por: Jochheim, Florian A., et al.
Publicado: (2021)

Targeting SARS-CoV-2 Polymerase with New Nucleoside Analogues
por: Daikopoulou, Vasiliki, et al.
Publicado: (2021)

Analysis and comparison of physiochemical properties, mutations and glycosylation patterns between RNA polymerase and membrane protein of SARS-CoV and SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
por: Naydenova, Katerina, et al.
Publicado: (2021)

Inhibition of the RNA-dependent RNA Polymerase of the SARS-CoV-2 by Short Peptide Inhibitors
por: Pant, Suyash, et al.
Publicado: (2021)

Single molecule activity assay for SARS-CoV-2 RNA dependent RNA polymerase
por: Chung, SangYoon, et al.
Publicado: (2022)

Electron Density Analysis of SARS-CoV-2 RNA-Dependent RNA Polymerase Complexes
por: Palko, Nadezhda, et al.
Publicado: (2021)

Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2020)

Molecular mechanism for conformational activation of SARS-CoV-2 RNA polymerase by nucleoside triphosphate
por: Ma, Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ke5ea652n6g345lrbh34fcrrt8